Protective effect of erythropoietin on myocardial apoptosis in rats exposed to carbon monoxide

Life Sciences

Volumn 148, Issue , 2016, Pages 118-124

  Rezaee, Mitra Asgharian ^a,b   Mohammadpour, Amir Hooshang ^a,c   Imenshahidi, Mohsen ^a   Mahmoudi, Mahmoud ^d   Sankian, Mojtaba ^d   Tsarouhas, Konstantinos ^e   Tsakalof, Andreas ^f   Tsatsakis, Aristidis Micheal ^f   Moallem, Seyed Adel ^a,c,g  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e General Hospital of Karditsa Perfecture   (Greece)

^f UNIVERSITY OF CRETE   (Greece)

^g MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bcl2; Carbon monoxide; Erythropoietin; Myocardial apoptosis

Indexed keywords

CARBON MONOXIDE; CARBOXYHEMOGLOBIN; CASPASE 3; PROTEIN BAX; PROTEIN BCL 2; RECOMBINANT ERYTHROPOIETIN; CARDIOTONIC AGENT; ERYTHROPOIETIN; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARBON MONOXIDE INTOXICATION; CARDIOTOXICITY; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; HEART MUSCLE CELL; HEART PROTECTION; MALE; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; RAT; TUNEL ASSAY; WESTERN BLOTTING; ANIMAL; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; DOSE RESPONSE; DRUG EFFECTS; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY; WISTAR RAT;

ANIMALS; APOPTOSIS; CARBON MONOXIDE; CARDIOTONIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROPOIETIN; HUMANS; MALE; MYOCARDIUM; MYOCYTES, CARDIAC; RATS; RATS, WISTAR; RECOMBINANT PROTEINS;

EID: 84959036497     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2016.02.007     Document Type: Article

References (37)

1. C. Reboul, J. Thireau, G. Meyer, L. Andre, P. Obert, O. Cazorla, and S. Richard Carbon monoxide exposure in the urban environment: an insidious foe for the heart? Respir. Physiol. Neurobiol. 184 2012 204 212 10.1016/j.resp.2012.06.010
2. M. Goldstein Carbon monoxide poisoning J. Emerg. Nurs. 34 2008 538 542
3. G. Lippi, G. Rastelli, T. Meschi, L. Borghi, and G. Cervellin Pathophysiology, clinics, diagnosis and treatment of heart involvement in carbon monoxide poisoning Clin. Biochem. 45 2012 1278 1285 10.1016/j.clinbiochem.2012.06.004
4. L.W. Kao, and K.A. Nanagas Carbon monoxide poisoning Emerg. Med. Clin. North Am. 22 2004 985 1018
5. E.J. Lavonas Carbon monoxide poisoning M.W. Shannon, S.W. Borron, M. Burns, Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose 2007 Saunders/Elsevier Philadelphia pp 1297 1307
6. J. Garg, P. Krishnamoorthy, C. Palaniswamy, S. Khera, H. Ahmad, D. Jain, W.S. Aronow, and W.H. Frishman Cardiovascular abnormalities in carbon monoxide poisoning Am. J. Ther. 2014 10.1097/mjt.0000000000000016
7. H.J. Kim, Y.K. Chung, K.M. Kwak, S.J. Ahn, Y.H. Kim, Y.S. Ju, Y.J. Kwon, and E.A. Kim Carbon monoxide poisoning-induced cardiomyopathy from charcoal at a barbecue restaurant: a case report Ann. Occup. Environ. Med. 27 2015 13 10.1186/s40557-015-0063-2
8. R.T. Burnett, R.E. Dales, J.R. Brook, M.E. Raizenne, and D. Krewski Association between ambient carbon monoxide levels and hospitalizations for congestive heart failure in the elderly in 10 Canadian cities Epidemiology 8 1997 162 167
9. S.R. Thom, D. Fisher, Y.A. Xu, K. Notarfrancesco, and H. Ischiropoulos Adaptive responses and apoptosis in endothelial cells exposed to carbon monoxide Proc. Natl. Acad. Sci. U. S. A. 97 2000 1305 1310
10. L.K. Weaver Clinical practice. Carbon monoxide poisoning N. Engl. J. Med. 360 2009 1217 1225
11. W. Jelkmann Molecular biology of erythropoietin Intern. Med. 43 2004 649 659
12. M. Lombardero, K. Kovacs, and B.W. Scheithauer Erythropoietin: a hormone with multiple functions Pathobiology 78 2011 41 53 10.1159/000322975
13. A.V. Santhanam, L.V. d'Uscio, and Z.S. Katusic Cardiovascular effects of erythropoietin an update Adv. Pharmacol. 60 2010 257 285 10.1016/B978-0-12-385061-4.00009-X (doi: B978-0-12-385061-4.00009-X [pii])
14. M. Joyeux-Faure, D. Godin-Ribuot, and C. Ribuot Erythropoietin and myocardial protection: what's new? Fundam. Clin. Pharmacol. 19 2005 439 446
15. K.J. Smith, A.J. Bleyer, W.C. Little, and D.C. Sane The cardiovascular effects of erythropoietin Cardiovasc. Res. 59 2003 538 548
16. G. Vogiatzi, A. Briasoulis, D. Tousoulis, N. Papageorgiou, and C. Stefanadis Is there a role for erythropoietin in cardiovascular disease? Expert. Opin. Biol. Ther. 10 2010 251 264 10.1517/14712590903547819
17. V. Mastromarino, M. Volpe, M.B. Musumeci, C. Autore, and E. Conti Erythropoietin and the heart: facts and perspectives Clin. Sci. (Lond.) 120 2011 51 63 10.1042/cs20100305
18. Erik Li, G.S. Regien, M. Peter van der, A.V. Adriaan, JvV Dirk, and HvG Wiek Protective effects of erythropoietin in cardiac ischemia: from bench to bedside J. Am. Coll. Cardiol. 48 2006 2161 2167
19. M. Asgharian Rezaee, S.A. Moallem, M. Imenshahidi, M. Farzadnia, and A.H. Mohammadpour Effects of erythropoietin on electrocardiogram changes in carbon monoxide poisoning: an experimental study in rats Iran J. Pharm. Res. 11 2012 1191 1199
20. S. Hara, T. Mukai, K. Kurosaki, H. Mizukami, F. Kuriiwa, and T. Endo Role of nitric oxide system in hydroxyl radical generation in rat striatum due to carbon monoxide poisoning, as determined by microdialysis Toxicology 239 2007 136 143
21. K.N. Iheagwara, S.R. Thom, C.S. Deutschman, and R.J. Levy Myocardial cytochrome oxidase activity is decreased following carbon monoxide exposure Biochim. Biophys. Acta 1772 2007 1112 1116
22. R. Favory, S. Lancel, S. Tissier, D. Mathieu, B. Decoster, and R. Neviere Myocardial dysfunction and potential cardiac hypoxia in rats induced by carbon monoxide inhalation Am. J. Respir. Crit. Care Med. 174 2006 320 325
23. C. Peers, and D.S. Steele Carbon monoxide: a vital signalling molecule and potent toxin in the myocardium J. Mol. Cell. Cardiol. 52 2012 359 365 10.1016/j.yjmcc.2011.05.013
24. L. Andre, J. Boissiere, C. Reboul, R. Perrier, S. Zalvidea, G. Meyer, J. Thireau, S. Tanguy, P. Bideaux, M. Hayot, F. Boucher, P. Obert, O. Cazorla, and S. Richard Carbon monoxide pollution promotes cardiac remodeling and ventricular arrhythmia in healthy rats Am. J. Respir. Crit. Care Med. 181 2010 587 595 10.1164/rccm.200905-0794OC
25. L.W. Kao, and K.A. Nanagas Toxicity associated with carbon monoxide Clin. Lab. Med. 26 2006 99 125
26. H.E. Liao, C.H. Lai, T.J. Ho, Y.L. Yeh, G.P. Jong, W.H. Kuo, L.C. Chung, P.Y. Pai, S.Y. Wen, and C.Y. Huang Cardio protective effects of lumbrokinase and dilong on second-hand smoke-induced apoptotic signaling in the heart of a rat model Chin. J. Physiol. 58 2015 188 196 10.4077/CJP.2015.BAD277
27. Y.S. Jung, J.S. Lee, Y.G. Min, J.S. Park, W.C. Jeon, E.J. Park, J.H. Shin, S. Oh, and S.C. Choi Carbon monoxide-induced cardiomyopathy Circ. J. 78 2014 1437 1444
28. A. Elsasser, K. Suzuki, and J. Schaper Unresolved issue regarding the role of apoptosis in the pathogenesis of ischemic injury and heart failure J. Mol. Cell. Cardiol. 32 2000 711 724
29. Z. Cai, D.J. Manalo, and G. Wei Hearts from rodent exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury Circulation 108 2003 79 85
30. A.F. Tramontano, R. Muniyappa, A.D. Black, M.C. Blendea, I. Cohen, L. Deng, J.R. Sowers, M.V. Cutaia, and N. El-Sherif Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway Biochem. Biophys. Res. Commun. 308 2003 990 994
31. C.J. Parsa, A. Matsumoto, J. Kim, R.U. Riel, L.S. Pascal, G.B. Walton, R.B. Thompson, J.A. Petrofski, B.H. Annex, J.S. Stamler, and W.J. Koch A novel protective effect of erythropoietin in the infarcted heart J. Clin. Invest. 112 2003 999 1007
32. C. Moon, M. Krawczyk, D. Ahn, I. Ahmet, D. Paik, E.G. Lakatta, and M.I. Talan Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats Proc. Natl. Acad. Sci. U. S. A. 100 2003 11612 11617 10.1073/pnas.1930406100
33. J.D. Ly, D.R. Grubb, and A. Lawen The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update Apoptosis 8 2003 115 128 doi: 5119089 [pii]
34. L. Skarka, and B. Ostadal Mitochondrial membrane potential in cardiac myocytes Physiol. Res. 51 2002 425 434
35. N. Paschos, M.G. Lykissas, and A.E. Beris The role of erythropoietin as an inhibitor of tissue ischemia Int. J. Biol. Sci. 4 2008 161 168
36. X. Chen, Y. Chen, Y. Bi, N. Fu, C. Shan, S. Wang, S. Aslam, P.W. Wang, and J. Xu Preventive cardioprotection of erythropoietin against doxorubicin-induced cardiomyopathy Cardiovasc. Drugs Ther. 21 2007 367 374 10.1007/s10557-007-6052-0
37. H. Kataoka, N. Kume, S. Miyamoto, M. Minami, M. Morimoto, K. Hayashida, N. Hashimoto, and T. Kita Oxidized LDL modulates Bax/Bcl-2 through the lectinlike Ox-LDL receptor-1 in vascular smooth muscle cells Arterioscler. Thromb. Vasc. Biol. 21 2001 955 960